A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors.
Saved in:
| Title: | A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors. |
|---|---|
| Authors: | LoRusso, Patricia M.1 patricia.lorusso@yale.edu, Infante, Jeffrey R.2,3, Kim, Kevin B.4, Burris, Howard A.2,3, Curt, Gregory5, Ugochi Emeribe5, Clemett, Delyth6, Tomkinson, Helen K.6, Cohen, Roger B.7, Burris, Howard A 3rd2,3 (AUTHOR), Emeribe, Ugochi5 (AUTHOR) |
| Source: | BMC Cancer. 3/6/2017, Vol. 17, p1-13. 13p. 1 Diagram, 4 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
